Insights from Digital Pharma Leaders
Refine Search
Pharmaceutical
Chinese artificial intelligence company XtalPi has agreed terms for a $250 million collaboration with Eli Lilly. 31 May 2023
Pharmaceutical
The life sciences industry has always been subjected to transparency requirements. To help avoid compliance violations that may lead to penalties, many life science organizations have ramped up their efforts to collect compliance data and streamline the reporting process. 10 May 2023
Pharmaceutical
Roche has announced the launch of the Institute of Human Biology (IHB), focussing on advancing research in the field of human model systems such as organoids. 5 May 2023
Biotechnology
US biotech success story Moderna has turned to one of the world’s leading tech companies as it seeks to stay at the forefront of advancing mRNA medicines. 21 April 2023
Pharmaceutical
An Expert View from Nicki Pow, head of delivery (digital and design), ramarketing. 13 April 2023
Pharmaceutical
There have been huge changes in the way highly regulated markets operate in recent years – caused by new regulations, technologies and demands. 6 April 2023
Pharmaceutical
Bayer has announced a move away from women’s health in early research as a priority area of focus for its pharmaceuticals division. 27 March 2023
Pharmaceutical
It seems every other day we hear of a new cyberattack in the news and it’s clear that these attacks are becoming an ever-growing, global concern. 27 March 2023
Biotechnology
Belgian drugmaker UCB has teamed up with US firm Aitia in an early drug discovery collaboration focused on the discovery and validation of new drug targets and candidates for Huntington’s disease. 15 March 2023
Pharmaceutical
UK-based medicines information company Datapharm has named Rich Cooper its new chief executive officer (CEO). 6 March 2023
Pharmaceutical
A report from the second edition of the AmpleLogic Pharma Summit, held last month at Hilton Cairo Heliopolis in Egypt. 2 March 2023
Pharmaceutical
Israel-based computational disease modelling company CytoReason and French pharma major Sanofi have announced an expansion of their collaboration. 23 January 2023
Biotechnology
UK-based artificial intelligence (AI) firm InstaDeep is to be acquired by immunotherapy specialist BioNTech for $440 million plus up to $243 million in milestone payments. 10 January 2023
Pharmaceutical
German pharma major Boehringer Ingelheim and US tech-based therapy firm Click Therapeutics have announced the launch of an expanded collaboration on a second prescription-based digital therapeutic (PDT). 20 December 2022
Pharmaceutical
An Expert View from Fiona Maini, principal, global compliance and strategy at Medidata Solutions, a Dassault Systèmes company. 14 November 2022
Pharmaceutical
Artificial intelligence (AI)-driven drug discovery company Insilico Medicine has announced a multi-year, multi-target strategic research collaboration with French pharma major Sanofi. 9 November 2022
article
The pace of innovation and digital transformation is increasing in the life science industry, particularly regarding regulatory compliance. As a result of the pandemic, when new age technologies were used to rapidly develop COVID-19 vaccines, treatments and tests, the use of automation and artificial intelligence to also optimize pharmacovigilance (PV) and regulatory compliance operations is on the rise. 6 November 2022
Pharmaceutical
Talking the talk alone is no longer enough for pharma companies where their digital strategies are concerned—now they need to walk the walk, too. 24 October 2022
Pharmaceutical
Danish diabetes giant Novo Nordisk and tech behemoth Microsoft have entered a new multi-year strategic collaboration. 12 September 2022
Pharmaceutical
COVID-19 has changed the world during the past couple of years, and one of its lasting legacies will be the need for speed and agility in all spheres of healthcare. 22 August 2022
Biotechnology
This week, we discuss a novel AI-driven approach to drug development, and its potential to transform the treatment of cancer and autoimmune diseases. 14 November 2024
Pharmaceutical
Digital therapeutics company GAIA has announced the signing of a licensing agreement for attexis with fellow German firm MEDICE Arzneimittel Pütter. 14 November 2024
Biotechnology
Privately-held Boston-based biopharma FogPharma has announced a name change and unveiled a new AI-based platform. 11 November 2024
Pharmaceutical
A review has found that complexities and inefficiencies within the UK’s health data infrastructure are hindering the effective use of these resources that are critical for improving people’s health. 8 November 2024
Pharmaceutical
An Expert View from Nick Petschek, Managing Director EMEA, Kotter International. 18 October 2024
Pharmaceutical
California-based AI company Suki has raised $70 million in new funding to accelerate the growth of its AI-powered voice solutions in healthcare. 11 October 2024
Pharmaceutical
Machine learning-enabled drug discovery and development company insitro has announced the execution of three strategic agreements with Eli Lilly. 10 October 2024
Biotechnology
China’s Quantum Pharmaceuticals has announced a significant licensing agreement between its biologics-focused subsidiary, Ailux Biologics, and Johnson & Johnson. 10 October 2024
Pharmaceutical
The UK has launched a new Regulatory Innovation Office (RIO), with the goal of accelerating new technologies, particularly in sectors like biotech and healthcare, by reducing regulatory barriers. 9 October 2024
Biotechnology
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Biotechnology
Californian companies Gilead Sciences and Genesis Therapeutics have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets. 10 September 2024
Biotechnology
ZipBio, a newly launched start-up based in Seattle, USA, is aiming to set a new standard in the development of biologics and gene therapies by utilizing generative AI technology. 9 September 2024
Pharmaceutical
An Expert View from Vikas Krishan, chief digital business officer at Altimetrik. 4 September 2024
Pharmaceutical
Otsuka Pharmaceuticals says that its subsidiaries Otsuka Precision Health, Inc. (OPH) and Click Therapeutics (Click) have launched Rejoyn (developed as CT-152). 19 August 2024
Pharmaceutical
CytoReason’s $80 million venture round may not have been the biggest in July, but it is one of a growing number of investor bets on AI powered drug discovery this year. 7 August 2024
Pharmaceutical
California’s ReviR Therapeutics has completed a $30 million series A financing round, bringing its total funding to $54 million. 29 July 2024
Pharmaceutical
An Expert View from Brendan Frey, founder and chief innovation officer of Deep Genomics. 4 July 2024
Biotechnology
AI-focused start-up Formation Bio has raised $372 million in a series D financing. 27 June 2024
Pharmaceutical
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%. 17 June 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze